Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.

T. C. Lynn, R. P. Hsieh, K. T. Lin, M. C. Shen, D. S. Chen, C. H. Wang, C. H. Liu, J. H. Wang, M. Y. Lai, M. F. Liou, M. R. Hsieh, C. Y. Chuang, R. Ting, Jacqueline Whang-Peng

研究成果: 雜誌貢獻文章同行評審

摘要

A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.
原文英語
頁(從 - 到)172-176
頁數5
期刊Zhonghua minguo weishengwu ji mianyixue zazhi
17
發行號3
出版狀態已發佈 - 八月 1 1984
對外發佈Yes

ASJC Scopus subject areas

  • Medicine(all)

指紋 深入研究「Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.」主題。共同形成了獨特的指紋。

引用此